Exploris Health joins the Heart-Brain Alliance
Originally published on explorishealth.com
Exploris Health has joined the Heart-Brain Alliance (Herz-Hirn-Allianz), launched in 2021 by professional societies, patient organizations, health insurers and industry representatives, with scientific partners and political supporters.
The alliance's goal is to reduce the impact of cardiovascular disease on patients and society. It initiates concrete measures to raise awareness, promote prevention, optimize patient pathways and advance research.
"We look forward to helping improve healthcare in Germany with our sophisticated AI technology in coordination with our very innovative alliance partners," said Peter Ruff, founder and CEO of Exploris Health AG.
Members include Novartis, Abbott, Novo Nordisk, AstraZeneca, Sanofi-Aventis, Siemens, the Bundesverband Niedergelassener Kardiologen e.V., and AOK Bayern and AOK Niedersachsen.
Cardiovascular disease in Germany
Cardiovascular disease is the most common cause of death worldwide. In Germany alone, more than 380,000 people die each year from cardiovascular diseases such as heart attack and stroke, around one in three deaths.
These diseases cause great personal suffering and place a heavy financial burden on healthcare and social systems. According to the World Heart Federation, up to 80% of illnesses and deaths can be attributed to modifiable or preventable risk factors.
Interested in how Cardio Explorer® applies to your coronary pathway? Our team is happy to walk you through the platform and the evidence behind it.
